Left ventricular hypertrophy detection using electrocardiographic signal

Cheng-Wei Liu1, Fu-Hsing Wu2, Yu-Lun Hu3

  • 1Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital Songshan Branch, National Defense Medical Center, Taipei, Taiwan.

Scientific Reports
|February 13, 2023
PubMed

Insights

A novel back propagation neural network (BPN) system effectively detects Left Ventricular Hypertrophy (LVH) using electrocardiogram (ECG) signals. This AI approach shows high accuracy, outperforming traditional ECG criteria and other AI models for early cardiovascular disease detection.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Artificial Intelligence in Medicine

Background:

  • Left Ventricular Hypertrophy (LVH) signifies subclinical organ damage and is linked to cardiovascular disease incidence.
  • Electrocardiogram (ECG) is a cost-effective, non-invasive tool for preliminary heart disease diagnosis.
  • Current ECG criteria for LVH rely on voltage thresholds of RS peaks.

Purpose of the Study:

  • To develop and evaluate an automated system for detecting LVH using ECG signals.
  • To compare the performance of the developed system against traditional ECG criteria and existing AI models.

Main Methods:

  • A two-step system was developed: 1) Extraction of 24 features from R-peak and S-valley amplitudes of 12-lead ECG, followed by ECG beat segmentation. 2) Training a back propagation neural network (BPN) with these features.
  • Echocardiography (ECHO) served as the gold standard for LVH diagnosis.
  • The BPN model was trained and tested on a dataset from a Taiwanese population, including 173 LVH cases and 1466 segmented ECG cycles.

Main Results:

  • The BPN model achieved high testing performance: accuracy (0.961), precision (0.958), sensitivity (0.966), and specificity (0.956).
  • The developed BPN system demonstrated superior detection performance compared to 7 traditional ECG criteria methods.
  • Performance also surpassed previously reported ECG-based artificial intelligence (AI) models for LVH detection.

Conclusions:

  • The developed BPN system offers a highly accurate and efficient method for detecting LVH from ECG signals.
  • This AI-driven approach shows significant potential for improving early diagnosis of cardiovascular conditions.
  • The system's performance suggests a valuable advancement over conventional diagnostic methods for LVH.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
20
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
41
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29